SVA.TO · Sernova Biotherapeutics Inc.
Canada · RS rating 31 · As of 2026-10-14
| Price | 0.12 CAD |
|---|---|
| 1-day change | +4.5% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 86 / 38 / 19 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 15 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $30.5M |